Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRTOS
2014-004082-25Phase 3Completed
- Sponsor
- Hellenic Cardiovascular Research Society
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in myocardial infarction (MI) and acute ST-segment elevation myocardial infarction (STEMI) comparing ticagrelor arm with clopidogrel arm (2 arms). Primary endpoint: Post-PCI corrected TIMI frame count. Started May 2015; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2014-004082-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004082-25.